Full Press Release Details
RICHMOND, Va.,Nov. 19, 2025/PRNewswire/ -- Indivior PLC (NASDAQ:INDV) today announced that it will participate in the Piper Sandler 37thAnnual Healthcare Conference:
INDV Positive Sentiment
Indivior to Participate in the Piper Sandler 37th Annual Healthcare Conference
Key Takeaway: Indivior PLC has announced its participation in the Piper Sandler 37th Annual Healthcare Conference. The company aims to transform opioid use disorder from a crisis to a recognized chronic disease through evidence-based treatments. Indivior continues to build its pipeline of product candidates to enhance its offerings in this area.
Price reaction · baseline $32.26 (2025-11-18 close) · hit pre-market · 1 other INDV headline(s) in the window, move may be shared
day 0 close · peak
+1.1%
Market Sentiment Analysis
POSITIVE FACTORS
- Indivior is actively participating in a major healthcare conference.
- The company is focused on addressing opioid use disorder, a significant health issue.
- Indivior is committed to expanding its portfolio of treatments for opioid use disorder.
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial adviceBest trade, last catalyst
+35%
120-day peak, hindsight
Typical move
5.4%
average across 2 past catalysts
Lead asset
RBP-6000
Phase 3 · Opioid Use Disorder
Frequently Asked Questions
What conference will Indivior participate in?
Indivior will participate in the Piper Sandler 37th Annual Healthcare Conference.
What is Indivior's focus in healthcare?
Indivior focuses on developing medicines for opioid use disorder (OUD).
What is Indivior's vision for OUD treatment?
Indivior envisions that all patients will have access to evidence-based treatment for OUD.
Where can I learn more about Indivior?
More information can be found on Indivior's official website at www.indivior.com.